As enclosed

Scheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

MEDIASSIST · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.6%Reaction day

₹388.90

prior close

₹376.25

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-4.2% vs market

Insurance peers, median of 12sector · industry level-0.1%-3.5% vs sector

On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 3.5 pts less than its Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.1

15m

-0.3

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.6+0.6-4.2-0.1-3.5

Next day

-3.1+1.7-4.8+0.4-3.4

-4.4+1.8-6.2+0.6-5.0

-6.6+3.4-10.0+1.5-8.2

-6.0+4.1-10.2+1.5-7.5

-5.9+4.1-10.0+1.3-7.2

-5.6+2.3-7.9-3.3-2.3

15d

-10.0+1.8-11.8-4.5-5.5

-5.0+10.8-15.7+2.9-7.9

-7.8+10.3-18.1-3.9-4.0

-8.6+14.9-23.5-3.4-5.2

UpDownMarket · Nifty Microcap 250Sector · Insurance peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Regional Director, South Western Region, Bengaluru has referred the Scheme of Amalgamation to the Hon'ble NCLT, Bengaluru. The original application under Section 233 was rejected because the scheme failed to meet fast-track merger requirements: no shareholder meeting was conducted, and no consideration or share swap ratio was provided despite the transfer not being between a holding company and its wholly-owned subsidiary. The matter is now being processed through the regular NCLT route under Section 232. This is an internal restructuring between two wholly-owned subsidiaries of Medi Assist and will not impact the company's consolidated financial statements.

Likely market impact

This is a procedural change within the group—the scheme is being rerouted through NCLT instead of the fast-track route. No material impact on Medi Assist's financial position or shareholding is expected as this involves only wholly-owned subsidiaries.